Intellia Soars as Data for Gene Editing Candidate in Hereditary Angioedema is Revealed
🌥️Trending News Intellia Therapeutics ($NASDAQ:NTLA), a leading biopharmaceutical company specializing in the development of gene editing therapies, recently saw its [...]
Intellia Therapeutics Stock Intrinsic Value – UBS Group AG Increases Intellia Therapeutics, Holdings by 270.9% in the Fourth Quarter
🌥️Trending News The company is developing both ex vivo and in vivo approaches to target diseases caused by genetic mutations, [...]
SG Americas Securities LLC Increases Intellia Therapeutics Stake by 83.4% in Q4
Trending News ☀️ SG Americas Securities LLC, a key investor in the biopharmaceutical company Intellia Therapeutics ($NASDAQ:NTLA), Inc., recently made [...]
-Saving Drug
Trending News ☀️ Intellia Therapeutics ($NASDAQ:NTLA) has emerged as a promising player in the field of drug discovery, providing new [...]
Intellia Therapeutics Shares Soar 12% on Positive Analyst Rating from Canaccord
Trending News ☀️ Shares of Intellia Therapeutics ($NASDAQ:NTLA) soared 12% today after Canaccord, a financial research firm, issued a Buy [...]
INTELLIA THERAPEUTICS Reports FY2022 Q4 Earnings With 39.6% Decrease in Revenue
Earnings Overview On February 23 2023, INTELLIA THERAPEUTICS ($NASDAQ:NTLA) released their fiscal year 2022 fourth quarter earnings results, which showed [...]
Intellia Therapeutics Posts Q4 Revenue Beat, Ends 2022 with $1.3B in Cash.
Trending News 🌥️ INTELLIA ($NASDAQ:NTLA): Richard E. Perlman, Director of Montrose Environmental Group, Inc., recently sold 400 shares of stock [...]
Unlocking the Power of the Genome: Intellia Therapeutics Leads the Way
Trending News 🌥️ This technology has the power to edit the DNA of cells, allowing scientists to alter the genetic [...]
Intellia Therapeutics, Share Price Drops to 12-Month Low of $32.47
Trending News 🌥️ This decline in share price is attributed to a variety of factors, ranging from the current market [...]
Intellia Therapeutics Receives Innovation Passport to Treat Rare Genetic Disorder Hereditary Angioedema
Trending News ☀️ INTELLIA THERAPEUTICS ($NASDAQ:NTLA) is a leading gene editing company that uses proprietary CRISPR genome editing technology to [...]
